China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294.SZ)
CNY 30.97
(1.44%)
CNY 30.97
(1.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 740.06 Million | 596.43 Million | 1.34 Billion | 718.58 Million | -114.51 Million | 34.9 Million |
| Net Income | 237.46 Million | 445.48 Million | 358.27 Million | 275.26 Million | 442.12 Million | 485.07 Million |
| Depreciation & Amortization | 113.91 Million | 96.97 Million | 99.35 Million | 83.1 Million | 82.77 Million | 55.31 Million |
| Deferred income taxes | -3.34 Million | -17.93 Million | -7.64 Million | 5.31 Million | -10.29 Million | -1.96 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 53.59 Million | 27.85 Million | 808.09 Million | 343.1 Million | -688.2 Million | -545.3 Million |
| Other non-cash items | 511.54 Million | 26.11 Million | 79.64 Million | 17.1 Million | 48.79 Million | 39.81 Million |
| Investing Cash Flow | -84.08 Million | -560.22 Million | -2.53 Billion | -128.33 Million | -273.1 Million | -209.9 Million |
| Investments in PPE | -87.49 Million | -138.41 Million | -68.11 Million | -142.5 Million | -88.61 Million | -113.9 Million |
| Acquisitions | 272.26 Million | 2.32 Million | 72.53 Million | 1.65 Million | 3.76 Million | 241.86 Thousand |
| Investment purchases | -7.08 Billion | -7.35 Billion | -4.01 Billion | -514.65 Million | -199.21 Million | -214.98 Million |
| Sales/Maturities of investments | 6.83 Billion | 6.92 Billion | 1.53 Billion | 5.2 Million | 6.87 Million | 100 Million |
| Other Investing Activities | -20 Million | -1.99 Million | -68.11 Million | 521.96 Million | 4.07 Million | 18.73 Million |
| Financing Cash Flow | -236.64 Million | -85 Million | 2.03 Billion | -390.46 Million | -237.59 Million | 847.14 Million |
| Debt repayment | -22.14 Million | -3.81 Million | -559.7 Million | -1.11 Billion | -1.24 Billion | -345.64 Million |
| Dividends payments | -100.84 Million | -75.63 Million | -27.68 Million | -63.89 Million | -64.99 Million | -101.69 Million |
| Common Stock Repurchased | - | - | - | 1.58 Million | -154.07 Million | -45.89 Million |
| Common Stock Issuance | - | - | - | -1.59 Million | 154.07 Million | - |
| Other Financing Activities | -113.65 Million | -1.81 Million | 2.63 Billion | 810.91 Million | 1.1 Billion | 1.29 Billion |
| Accounts receivables | 40.02 Million | -11.73 Million | 799.83 Million | 390.43 Million | -647.63 Million | -574.57 Million |
| Accounts payables | -92.32 Million | 56.23 Million | 4.14 Million | 15.89 Million | -11.64 Million | 118.03 Million |
| Inventory | 107 Million | 1.27 Million | 11.76 Million | -68.53 Million | -18.63 Million | -86.79 Million |
| Other working capital | -1.11 Million | -17.93 Million | -7.64 Million | 5.31 Million | -10.29 Million | -458.5 Million |
| Cash at beginning of period | 1.53 Billion | 1.57 Billion | 737.87 Million | 538.08 Million | 1.16 Billion | 491.15 Million |
| Cash at end of period | 1.96 Billion | 1.53 Billion | 1.57 Billion | 737.87 Million | 538.08 Million | 1.16 Billion |
| Capital Expenditure | -87.49 Million | -138.41 Million | -68.11 Million | -142.5 Million | -88.61 Million | -113.9 Million |
| Effect of forex changes on cash | 10.52 Million | - | 0.40 | -0.69 | - | 0.58 |
| Net cash flow / Change in cash | 429.85 Million | -48.79 Million | 841.38 Million | 199.78 Million | -625.2 Million | 672.14 Million |
| Free Cash Flow | 652.56 Million | 458.02 Million | 1.27 Billion | 576.07 Million | -203.12 Million | -78.99 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 96.73 Million | 163.94 Million | 152.02 Million | -226.6 Million | 237.46 Million | 138.14 Million |
| Depreciation & Amortization | - | 26.12 Million | 26.12 Million | 28.93 Million | 113.91 Million | -48.28 Million |
| Deferred income taxes | - | - | - | - | -3.34 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -67.24 Million | - | 147.02 Million | 53.59 Million | 400.85 Million |
| Other non-cash items | -34.56 Million | -5.9 Million | -16.7 Million | 211.8 Million | 511.54 Million | -351.13 Million |
| Investing Cash Flow | -1.28 Billion | 1.41 Billion | -229.16 Million | 488.88 Million | -84.08 Million | -674.3 Million |
| Investments in PPE | -67.6 Million | -30.49 Million | -21.17 Million | -12.94 Million | -87.49 Million | -19.36 Million |
| Acquisitions | 118.82 Thousand | 38.43 Thousand | 109.42 Million | 234.72 Million | 272.26 Million | 37.2 Million |
| Investment purchases | -1.8 Billion | -1.7 Billion | -1.13 Billion | -2.65 Billion | -7.08 Billion | -1.1 Billion |
| Sales/Maturities of investments | 741.42 Million | 3.15 Billion | 811.45 Million | 2.93 Billion | 6.83 Billion | 407.84 Million |
| Other Investing Activities | -161.88 Million | 1.49 Billion | -207.98 Million | -19.99 Million | -20 Million | 0.43 |
| Financing Cash Flow | -22.23 Million | -147.92 Million | -52.85 Thousand | -43.01 Million | -236.64 Million | -56.72 Million |
| Debt repayment | -22.14 Million | - | - | -2.83 Million | -22.14 Million | -20.14 Million |
| Dividends payments | -151.27 Million | -151.27 Million | - | - | -100.84 Million | -100.84 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -22.23 Million | -145.98 Million | -52.85 Thousand | -43.01 Million | -113.65 Million | 64.26 Million |
| Accounts receivables | - | -48.74 Million | - | 40.02 Million | 40.02 Million | 485.84 Million |
| Accounts payables | - | - | - | - | -92.32 Million | - |
| Inventory | - | -18.5 Million | - | 107 Million | 107 Million | -84.98 Million |
| Other working capital | - | - | - | - | -1.11 Million | - |
| Cash at beginning of period | 3.24 Billion | 1.86 Billion | 1.94 Billion | 1.34 Billion | 1.53 Billion | 1.94 Billion |
| Cash at end of period | 1.98 Billion | 3.25 Billion | 1.84 Billion | 1.96 Billion | 1.96 Billion | 1.34 Billion |
| Capital Expenditure | -67.6 Million | -30.49 Million | -21.17 Million | -12.94 Million | -87.49 Million | -19.36 Million |
| Effect of forex changes on cash | -0.04 | 6481.00 | 485.54 | 11.68 Million | 10.52 Million | -7.06 Million |
| Net cash flow / Change in cash | -1.25 Billion | 1.39 Billion | -105.34 Million | 618.71 Million | 429.85 Million | -598.51 Million |
| Free Cash Flow | -5.43 Million | 101.41 Million | 114.14 Million | 148.22 Million | 652.56 Million | 120.22 Million |
688766
PGEL
ATO
ABSSF
1451
SNS